Developmental defects: a final common pathway of teratogenicity?
D000014:Abnormalities, Drug-Induced / Q000209:etiology* / Q000517:prevention & control; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D001639:Bicarbonates / Q000627:therapeutic use; D002746:Chlorpromazine / Q000494:pharmacology; D005314:Embryonic and Fetal Development; D005260:Female; D007103:Immobilization; D010634:Phenobarbital / Q000494:pharmacology; D011247:Pregnancy; D011312:Pressure; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012459:Salicylates / Q000009:adverse effects; D014592:Uterine Hemorrhage / Q000139:chemically induced / Q000150:complications; D014599:Uterus
D001639:Bicarbonates; D012459:Salicylates; D012110:Reserpine; D002746:Chlorpromazine; D010634:Phenobarbital